Law firm Lowenstein Sandler announced that James Shehan, former general counsel of Novo Nordisk, will join the firm as a senior counsel in its life sciences practice and as head of the firm’s FDA regulatory practice.
Former general counsel of Novo Nordisk joins Lowenstein Sandler
